Trial Profile
A study to evaluate treatment adherence to once weekly exenatide or once daily liraglutide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Mar 2016 New trial record